GammaTile Therapy

Education

Learn more about GammaTile Therapy

We invite you to browse through the videos, read the FAQs, and take a deep dive into the science behind GammaTile Therapy by watching the webinars and reading the clinical publications.

Note: In January 2020, GammaTile Therapy was FDA cleared for the treatment of newly diagnosed malignant brain tumors of all types in addition to the existing clearance for recurrent brain tumors. 

Physician Interviews

WeTV National | March 21, 2020 | New Approach for the Treatment of Brain Tumors” on The Lifestyle List

March 18, 2020 | GammaTile Therapy Physician Testimonial | Dr. McCracken, Neurosurgeon At Piedmont Atlanta Hospital

Ohio CBS | November 15, 2019 | New brain cancer therapy provides radiation right at site of tumor 

Videothumb2

Ohio CBS | August 20, 2019 | Mayfield brain and spine neurosurgeon using new radiation therapy.

Arizona PBS | June 11, 2019 | Implantable brain tumor treatment GammaTile Therapy with Dr. David Brachman.

Florida NBC | March 20, 2020 | GammaTile: New Approach For The Treatment Of Brain Tumors

North Carolina CBS | January 24, 2020 | Vidant Health™ and the ECU Brody School of Medicine successfully perform first-in-state GammaTile procedure

Cronkite News Division of Arizona PBS | Oct 22, 2019 | Battling brain tumors with time-released radiation

Arizona CBS | August 14, 2019 | New therapy to slow down brain tumors forever changes Arizona woman's life.

Minnesota CBS | February 14, 2019 | New brain cancer treatment GammaTile Therapy at University of Minnesota with survivor Linda Tinega.

Physician Testimonial Video

Dr Clark Chen, University of Minnesota

 

Introducing GammaTile Therapy

GammaTile Technology

GammaTile Science

Surgical Footage

Glioma Case Example I

Glioma Case Example II

Brain Metastases Case Example

Meningioma Case Example

“What I like about GammaTile is that they’re taking a radiation technology that already exists and making it safer and easier to deliver…Should be equally effective and faster to implant after tumor surgery…[It’s] better for patients (less anesthesia time) and safer for the staff (less exposure in the operating room).”

  Dr Helen Shih  

Radiation Oncologist, Massachusetts General Hospital

FAQs

Below are the answers to important questions about GammaTile Therapy for people with brain tumors and their caregivers. Speak with your treatment team to see if GammaTile Therapy is right for you or your loved one.

 

Frequently asked questions

#demo.question.question1#


#demo.question.question1.answer1#




#demo.question.question2#


#demo.question.question2.answer1#

  1. #demo.question.question2.answer2#
  2. #demo.question.question2.answer3#
  3. #demo.question.question2.answer4#
  4. #demo.question.question2.answer5#




#demo.question.question3#


#demo.question.question3.answer0#

  1. #demo.question.question3.answer1#
  2. #demo.question.question3.answer2#
  3. #demo.question.question3.answer3#
  4. #demo.question.question3.answer4#
  5. #demo.question.question3.answer5#




#demo.question.question4#


#demo.question.question4.answer1#





 

Webinars

American Brain Tumor Association | February 27, 2020

Webinar: Therapies Given During Surgery 

This webinar provides a detailed overview of surgically implanted brain tumor therapies, including GammaTile Surgically Targeted Radiation Therapy (STaRT). Dr John A. Boockvar, the director of the Brain Tumor and Pituitary/Neuroendocrine Center at Lenox Hill, discusses various treatment options, highlights their differences, and provides guidance on how patients can talk with their heath team about their care plan. Watch here

The Musella Foundation | May 26, 2019

Webinar: GammaTiles for Brain Tumors

This webinar provides a detailed overview of surgically implanted brain tumor therapies, including GammaTile Surgically Targeted Radiation Therapy (STaRT). Dr John A. Boockvar, the director of the Brain Tumor and Pituitary/Neuroendocrine Center at Lenox Hill, discusses various treatment options, highlights their differences, and provides guidance on how patients can talk with their heath team about their care plan. Watch here

 

Clinical Publications

JOURNAL OF NEUROSURGERY 2019
Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas

David G. Brachman, MD, Emad Youssef, MD, Christopher J. Dardis, MD, Nader Sanai, MD, Joseph M. Zabramski, MD, Kris A. Smith, MD, Andrew S. Little, MD, Andrew G. Shetter, MD, Theresa Thomas, MS, Heyoung L. McBride, MD, MS, Stephen Sorensen, PhD, Robert F. Spetzler, MD, and Peter Nakaji, MDl, in the Journal of Neurosurgery. 2018:1-10. doi:10.3171/2018.7.jns18656. Read here

AANS ANNUAL MEETINGS 2019 – 2020
Surgically targeted radiation therapy: a prospective trial in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial

AANS Annual Meeting 2019. Read here

Novel permanently implanted 3D-collagen tile for intraoperative brachytherapy in a patient with recurrent glioblastoma

AANS Annual Meeting 2020. Read here

ABS ANNUAL MEETING 2019
Surgically targeted radiation therapy: safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial.

ABS Annual Meeting 2019. Read here

SNO ANNUAL MEETING 2019

RTHP-32. First experience with gamma tile permanent implants for recurrent brain tumors

Clara Ferreira, Parham Alaei, Clark Chen, Margaret Reynolds, David Sterling, Kathryn Dusenbery, Neuro-Oncology. Volume 21, Issue Supplement_6, November 2019, Page vi216, doi:10.1093/neuonc/noz175.903.

Read here